Liangbin Lin

2.3k total citations · 1 hit paper
12 papers, 1.6k citations indexed

About

Liangbin Lin is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Liangbin Lin has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Liangbin Lin's work include Immune Cell Function and Interaction (4 papers), interferon and immune responses (3 papers) and Immunotherapy and Immune Responses (3 papers). Liangbin Lin is often cited by papers focused on Immune Cell Function and Interaction (4 papers), interferon and immune responses (3 papers) and Immunotherapy and Immune Responses (3 papers). Liangbin Lin collaborates with scholars based in China, United States and Denmark. Liangbin Lin's co-authors include Hongbo Hu, Huiyuan Zhang, Hui Yu, Zhiqiang Zhang, Xiang Hu, Yanli Tong, Yanqiu Gong, Lunzhi Dai, Jun Mou and Yantong Liu and has published in prestigious journals such as Scientific Reports, Small and Frontiers in Immunology.

In The Last Decade

Liangbin Lin

10 papers receiving 1.6k citations

Hit Papers

Targeting NF-κB pathway for the therapy of diseases: mech... 2020 2026 2022 2024 2020 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangbin Lin China 6 749 573 309 230 131 12 1.6k
Siamak Sandoghchian Shotorbani Iran 21 665 0.9× 392 0.7× 259 0.8× 263 1.1× 118 0.9× 58 1.6k
Zhe Jian China 28 1.1k 1.5× 651 1.1× 319 1.0× 130 0.6× 167 1.3× 62 2.4k
Bastian Popper Germany 21 897 1.2× 377 0.7× 197 0.6× 232 1.0× 146 1.1× 60 1.8k
JooYeon Jhun South Korea 29 804 1.1× 591 1.0× 168 0.5× 283 1.2× 168 1.3× 67 1.8k
Bahman Rashidi Iran 20 1.1k 1.4× 450 0.8× 417 1.3× 219 1.0× 179 1.4× 77 2.3k
Yang Jiao China 26 1.0k 1.3× 302 0.5× 364 1.2× 155 0.7× 178 1.4× 86 1.8k
Xiaoyi Hu China 17 1.0k 1.3× 565 1.0× 364 1.2× 569 2.5× 145 1.1× 31 2.5k
Rükset Attar Türkiye 22 571 0.8× 329 0.6× 179 0.6× 162 0.7× 94 0.7× 122 1.7k

Countries citing papers authored by Liangbin Lin

Since Specialization
Citations

This map shows the geographic impact of Liangbin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangbin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangbin Lin more than expected).

Fields of papers citing papers by Liangbin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangbin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangbin Lin. The network helps show where Liangbin Lin may publish in the future.

Co-authorship network of co-authors of Liangbin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liangbin Lin. A scholar is included among the top collaborators of Liangbin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangbin Lin. Liangbin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Su, Xu, Hui Yu, Xuerui Chen, et al.. (2024). Systemic lupus erythematosus: pathogenesis and targeted therapy. Molecular Biomedicine. 5(1). 54–54. 16 indexed citations
2.
Liu, Yanting, et al.. (2024). Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy. Frontiers in Cell and Developmental Biology. 12. 1514595–1514595. 13 indexed citations
3.
Yang, Wenyong, et al.. (2024). Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas. Scientific Reports. 14(1). 11874–11874. 1 indexed citations
4.
Lin, Liangbin. (2024). Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome. American Journal of Cancer Research. 14(6). 2731–2754.
5.
Yu, Hui, Wenyong Yang, Xu He, et al.. (2024). Mechanism study of ubiquitination in T cell development and autoimmune disease. Frontiers in Immunology. 15. 1359933–1359933. 4 indexed citations
6.
Yang, Wenyong, et al.. (2024). Identification of EMT-associated prognostic features among grade II/III gliomas. Scientific Reports. 14(1). 2822–2822. 4 indexed citations
8.
Lin, Liangbin, et al.. (2023). Comment on “An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy”. Small. 20(18). e2302812–e2302812. 2 indexed citations
9.
Lin, Liangbin, Hui Yu, Li Li, et al.. (2023). TRIM55 promotes noncanonical NF-κB signaling and B cell–mediated immune responses by coordinating p100 ubiquitination and processing. Science Signaling. 16(806). eabn5410–eabn5410. 11 indexed citations
10.
Yu, Hui, Liangbin Lin, Zhiqiang Zhang, Huiyuan Zhang, & Hongbo Hu. (2020). Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduction and Targeted Therapy. 5(1). 209–209. 1422 indexed citations breakdown →
11.
Lin, Liangbin, Xiang Hu, Huiyuan Zhang, & Hongbo Hu. (2019). Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy. Frontiers in Immunology. 10. 1398–1398. 50 indexed citations
12.
Li, Qijie, Liangbin Lin, Yanli Tong, et al.. (2018). TRIM29 negatively controls antiviral immune response through targeting STING for degradation. Cell Discovery. 4(1). 13–13. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026